Research study Program year 2025 Source: CMS Open Payments

0000000000000000000000000000000000000000000000000000000000000000214440

Research payments

$6,474,467

30 payments

Through program year 2025, $6,474,467 in research payments was reported against 0000000000000000000000000000000000000000000000000000000000000000214440, across 30 payments, paid by GlaxoSmithKline, LLC..

Paid by
GlaxoSmithKline, LLC.
ClinicalTrials.gov
No trial number was reported for this study

By program year

4 rows
Year Kind Amount Payments
2025 Research $1,593,129 5
2024 Research $1,363,507 4
2021 Research $2,339,130 12
2019 Research $1,178,701 9

Breakdown

Who paid Research payments · program years 2019–2025
  1. GlaxoSmithKline, LLC. $6,474,467 30 payments
Who received the money Research payments · program years 2019–2025
  1. Dana Farber Partners Cancercare INC Organisation paid for research $6,474,467 30 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

1 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record